Inmunoglobulina subcutánea: Tratamiento en polineuropatía desmielinizante inflamatoria crónica

Nogués, Martín A; Varela, Francisco J; Seminario, Gisela; Insúa, María C; Bezrodnik, Liliana.
Medicina (B.Aires) ; 76(1): 36-39, feb. 2016. ilus, graf, tab
Artículo en Español | LILACS | ID: biblio-841537

Documentos relacionados

  1. [Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
  2. [Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
  3. Relative leucopenia and hemolytic anemia following infusion of immunoglobulin.
  4. Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia.
  5. Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational study.
  6. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort.
  7. Current clinical management of CIDP with immunoglobulins in France: An expert opinion.
  8. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
  9. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
  10. Serum neurofilament light chain does not detect self-reported treatment-related fluctuations in chronic inflammatory demyelinating polyneuropathy.